An enzyme-linked immunometric assay for cortisol based on idiotype-anti-idiotype reactions

Toshifumi Niwa1, Takayuki Kobayashi, Pi Sun

  • 1Department of Medical Technology, Health Sciences, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.

Analytica Chimica Acta
|March 21, 2009
PubMed

Insights

We developed a novel enzyme-linked immunometric assay for measuring cortisol. This assay demonstrates significantly higher sensitivity and practical specificity for monitoring pituitary-adrenal axis function.

Area of Science:

  • Biochemistry
  • Immunology
  • Assay Development

Background:

  • Cortisol levels in body fluids are crucial for assessing pituitary-adrenal axis function.
  • Existing assay methods may have limitations in sensitivity or specificity.

Purpose of the Study:

  • To establish a highly sensitive and specific enzyme-linked immunometric assay (ELIA) for cortisol detection.
  • To utilize idiotype-anti-idiotype antibody reactions for enhanced assay performance.

Main Methods:

  • Generation of anti-idiotype monoclonal antibodies (alpha-type and beta-type) against an anti-cortisol antibody using hybridoma technology.
  • Development of a noncompetitive ELIA employing a combination of selected alpha-type and beta-type antibodies.
  • Detection of cortisol via biotin labeling and colorimetric monitoring with peroxidase-labeled streptavidin.

Main Results:

  • The developed ELIA exhibited approximately threefold higher sensitivity compared to a competitive ELISA.
  • The assay achieved a detection limit of 90 pg (248 fmol) for cortisol.
  • The assay demonstrated practical specificity suitable for determining normal urinary cortisol levels.

Conclusions:

  • The novel idiotype-anti-idiotype based ELIA offers superior sensitivity for cortisol measurement.
  • This assay provides a valuable tool for monitoring pituitary-adrenal axis function.
  • The assay's enhanced sensitivity and specificity contribute to more accurate clinical assessments.